Advanced Headache Diagnosis & Management 2022

Philadelphia, PA US
June 25, 2022 to June 26, 2022


This site will not work on Internet Explorer 8. Please use:

Google Chrome      Mozilla FIREFOX   Safari     Opera


Successful Completion

To successfully complete this activity, the required evaluation must be completed no later than Tuesday, August 9, 2022. Thereafter, the evaluation will no longer be available and credits will not be issued. No refunds will be offered for failure to complete the required evaluation by the stated deadline.

Target Audience

This course is designed for physicians and nurses.

Learning Objectives

Following this educational activity, learners will be able to:

  1. Demonstrate clinical skills in injection techniques to alleviate myofascial pain.
  2. Compose appropriate management plans in infusion therapy for refractory headache disease.
  3. Distinguish between different headache diagnoses.
  4. Differentiate headache symptoms to appropriately diagnose and treat.
  5. Construct appropriate management plans for patients presenting with headache disorders.
  6. Analyze peer reviewed publications for evidence based practice in treating patients with headache disorders.
  7. Create advocacy plans for patients to help with decreasing the stigma associated with headache disorders.
Additional information
Jefferson Content Development By: 
Jefferson College of Nursing
Content Areas: 
Course Format: 
Live Conference
Hands on training
Course summary
Available credit: 
  • 9.00 AMA PRA Category 1 Credit
  • 9.00 Attendance
  • 9.00 CNE
Course opens: 
Course expires: 
Event starts: 
06/25/2022 - 8:00am EDT
Event ends: 
06/26/2022 - 12:00pm EDT

Commercial/In-Kind Support

This educational activity received no commercial/in-kind support.

This draft agenda is subject to change, which may affect the credit count.

Recording and Photography Strictly Prohibited

Unauthorized recording or photography at a Jefferson-sponsored event is strictly prohibited. Individuals found violating this policy will be removed from the online activity or asked to leave from the live activity. No credits or refund will be issued.

TJU Hamilton Building
1001 Locust Street
Rector Clinical Skills and Simulation Center
Philadelphia, PA 19107
United States



Conflict of interest

Thomas Jefferson University endorses the Standards for Integrity and Independence in Accredited Continuing Education and the policies that supplement the Standards.

All planners, faculty, and others in control of educational content are required to disclose any relevant financial relationships with ACCME defined ineligible companies within the past 24 months. Any conflicts of interests have been mitigated prior to this educational activity.

Such disclosures will be available prior to the start of the activity. ​Jefferson conflict of interest mitigation process may result in changes to the program agenda.

Planning Committee

The following planning committee members have no financial relationships to disclose.
Hannah R. Smith, PhD

The following planning committee members have financial relationships to disclose.
Simy Parikh, MD-Activity Director
Advisor: Biohaven; Honoraria: Medlink Neurology
Joanne P. Robinson PhD, RN, CNE, FAAN
Researcher: Pfizer


The following faculty have no financial relationship to disclose.
Claire Ceriani, MD
Abigail L. Chua, DO
Jennifer Kengeter, PsyD
Hannah Smith, PhD
Shuhan Zhu, MD

The following faculty have financial relationships to disclose.
Larry Charleston IV, MD
Consultant/Advisor: Abbvie/Allergan, Amneal, Satsuma
Brad Klein, PhD
Researcher: Abbvie Consultant: Abbvie, Amgen, Eli Lilly Speaker: Abbvie, Amgen, Biohaven, Eli Lilly, Lundbeck, Teva, Theranica; Ownership interest: AppsbyDocs,LLC
Michael Marmura, MD
Speaker: Amgen/Novartis, Eli Lilly Consultant: Lumbeck, Theranica; Researcher: Teva
Stephanie Nahas, MD
Consultant: Allergan/AbbVie, Eli Lilly; Advisor: Allergan/AbbVie
Simy Parikh, MD
Advisor: Biohaven; Honoraria: MedLink Neurology
Stewart Tepper, MD
Researcher: Abbvie, Amgen, Biohaven, Eli Lilly, Lundbeck, Neurolief, Satsuma
Consultant: Abbvie, Aeon, Alphasights, Amgen, Aruene, Atheneum, Axsome Therapeutics, Becker Pharmaceutical Consulting, BioDelivery Sciences International, Biohaven, ClearView Healthcare Partners, Click Therapeutics, CoolTech, CRG, Currax, Eli Lilly, Expert Connect, FCB Health, Fenix, GLG, Guidepoint Global, Health Advances, Health Science Communications, Impel, Interactive Forums, Keyquest, Krog and Partners, Lundbeck, M3 Global Research, Magnolia Innovation, MJH Holdings, Neurofront Therapeutics, Neurolief, P Value Communications, Pain Insight, Inc., Palion Medical, Pulmatrix, Satsuma, Slingshot Insights, Spherix Global Insights, Strategy Inc., System Analytics, Taylor and Francis, Teva, Therancia, Tremeau, Trinity Partners, Unity HA, Xoc, Zosano
Advisor: Abbvie, Aeon, Amgen, Axsome Therapeutics, Biohaven, ClickTherapeutics, CoolTech, Currax, Decision Resources, Defined Health, DRG, Eli Lilly, Impel, Lundbeck, Neurolief, Palion Medical, Pulmatrix, SAI MedPartners, Satsuma, Theranica, Tremeau, Unity HA, Xoc, Zosano
Hsiangkuo Yuan, MD, PhD
Royalties or Patent Beneficiary: Cambridge University Press, Teva
Thomas Berk, MD
Advisor: Abbive
William Young, MD
Researcher: Abbvie, Aeon, Lundbeck, Satsuma, Teva

Off‐label/Investigational Use

All faculty/presenters/authors at Thomas Jefferson University sponsored events are required to disclose whether or not their content contains information of commercial products/devices that are unlabeled for use or investigational uses of products not yet approved.  Product(s) is/are not included in the labeling approved by the U.S. FDA for the treatment of disease(s).

Content Disclaimer

The views expressed in this activity are those of the faculty. It should not be inferred or assumed that they are expressing the views of any manufacturer of pharmaceuticals or devices or Thomas Jefferson University.

It should be noted that the recommendations made herein with regard to the use of therapeutic agents, varying disease states, and assessments of risk, are based upon a combination of clinical trials, current guidelines, and the clinical practice experience of the participating presenters. The drug selection and dosage information presented in this activity are believed to be accurate. However, participants are urged to consult all available data on products and procedures before using them in clinical practice. support of improving patient care, Thomas Jefferson University is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.


Credit Designation

Physicians: This educational activity is designated for a maximum of 9.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses: This activity awards 9.0 nursing contact hours.

Other Healthcare Professionals: This educational activity is designated for 9.0 AMA PRA Category 1 Credits™. Participants should claim only the credit commensurate with the extent of their participation in the activity.

Credit count includes .25 credit (15 minutes) for completion of the required evaluation.

Available Credit

  • 9.00 AMA PRA Category 1 Credit
  • 9.00 Attendance
  • 9.00 CNE


Please login or register to take this course.


To register for this activity, click here. This link will take you to another Jefferson webpage.